TABLE 1.
Characteristics of recruited participants included in this meta‐analysis.
| Reference |
Total N |
Age (year) [Mean (SD)] |
Gender [Male (%)] |
Time post stroke [Mean (SD)] |
Lesion side [right (%)] | phase |
|---|---|---|---|---|---|---|
| Fleming et al. (2017) | 25 |
DS: 59.8 (13.1) SS: 59.8 (13.1) |
NR |
DS: 19.7 (27.4) m SS: 19.7 (27.4) m |
DS: 12(48%) SS: 12(48%) |
chronic |
| Long et al. (2018) | 62 |
DS: 55.90 (8.89) SS: 57 (11.78) Sham:56.85(5.48) |
DS: 16 (76%) SS: 16 (76%) Sham: 15(75%) |
DS: 19.81 (2.98) d SS: 19.57 (2.34) d Sham: 19.05(2.74) |
DS: 11(52%) SS: 11(52%) Sham: 11(55%) |
subacute |
| Taud et al. (2021) | 30 |
DS: 58.3 (12.8) SS: 60.3 (10.3) |
DS: 11 (73%) SS: 12 (80%) |
DS: 21.9 (17.2) m SS: 28.8 (35.3) m |
DS: 8(53%) SS: 8(53%) |
chronic |
| Cai (2020) | 103 |
DS: 55.37 (8.16) SS: 55.00 (7.55) |
DS: 29 (56%) SS: 27 (53%) |
DS: 60.31 (16.94) d SS: 61.39 (15.49) d |
DS: 26(50%) SS: 27(53%) |
subacute |
| Cao et al. (2022) | 40 |
DS: 51.80 (15.45) SS: 48.75 (13.24) |
DS: 12 (60%) SS: 11 (55%) |
DS: 45.85 (20.56) d SS: 41.90 (24.86) d |
DS: 12(60%) SS: 7(35%) |
subacute |
| Ren et al. (2018) | 60 |
DS: 51.2(3.6) SS:49.6 (4.3) |
DS: 19 (63%) SS: 17 (57%) |
NR | NR | NR |
| Hsu et al. (2021) | 27 |
DS: 59.1 (11.4) Sham: 59.2 (11.8) |
DS: 9 (69%) Sham: 6 (43%) |
DS: 20.7 (3.5) d Sham: 21.1 (5.3)d |
DS: 9 (69%) Sham: 7 (50%) |
subacute |
| Kim (2021) | 30 |
DS: 60.2(5.3) Sham: 60.33(6.33) |
DS: 7 (47%) Sham: 8 (53%) |
DS: 12.13(1.84)m Sham: 10.93(1.94)m |
DS: 7 (47%) Sham: 8 (53%) |
chronic |
| Lindenberg et al. (2010) | 20 |
DS: 61.7 (14.7) Sham: 55.8(12.9) |
DS: 8 (80%) Sham: 7 (70%) |
DS: 30.5(21.4)m Sham: 40.3(23.4)m |
DS: 4 (40%) Sham: 3 (30%) |
chronic |
| Ji (2014) | 29 |
DS: 64.2(11.9) Sham: 62.3(12.2) |
DS: 11 (73%) Sham: 10(71%) |
DS: 8.1 (1.5) m Sham: 8.2 (1.6)m |
NR | chronic |
Abbreviations: DS: dual‐site NIBS; NR: not reported; SS: single‐site NIBS.